Sentence examples for history progression from inspiring English sources

The first component involved the development of a mathematical model of HPV natural history, progression to CIN and cervical cancer within the UK population.

The natural history, progression and outcome in patients with a range of musculoskeletal conditions have been described in primary care [ 13- 17] and secondary care (i.e. rheumatology) [ 18- 20] settings.

Inherently, the information obtained from such a study would be very important and critical in the understanding of the natural history, progression and possible mechanisms to incident disability and their trajectory observed in clinical practice.

21 Diabetic foot ulcers may be classified in stages according to the natural history progression: 1) normal foot; 2) high risk foot; 3) ulcerated foot; 4) infected foot; 5) necrotic foot.

In all subsequent cycles, risk factor trajectories were updated according to the natural history progression specified by the UKPDS 68 panel equations for HbA1c, systolic blood pressure (SBP), total cholesterol:high density lipoprotein ratio (TC:HDL).

They are enriched with candidate genes belonging to the insulin/insulin like signaling (IIS) pathway, including PAR 3 (bazooka, GB10346), PI3K (phosphoinositide 3-kinase, GB17429), PDK1 (phosphoinositide-dependent kinase-1, GB15780), and IRS (insulin receptor substrate, GB11037), that can govern resource allocation to reproduction and life-history progression [13].

Thus it is possible to view HCV natural history or progression as 3 groups; those that progress to cirrhosis within 20 years, those that progress over 20 50 years, and those that do not progress within their lifetimes.

To describe the natural history and progression of visual loss in eyes with untreated neovascular age-related macular degeneration (AMD).

This article reviews the pathophysiology of the latent form of Mycobacterium tuberculosis along with its natural history and progression in infected tissues.

To characterize the medical history, disease progression, and treatment of current-era patients with the rare diseases Fontan-associated protein-losing enteropathy (PLE) and plastic bronchitis.

ICS clearly improve asthma control in children with mild to moderate persistent asthma, but it is not clear that they can alter the natu-ral history and progression of asthma.